Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA stomach ache on Mounjaro is one of the most commonly reported side effects of tirzepatide treatment. It usually shows up in the first few weeks, often after starting or increasing a dose, and for most people it eases as the body adjusts. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses suitability before any treatment begins, and they are the right person to speak to if abdominal discomfort is affecting your daily life or is more severe than mild.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide works on two gut-hormone receptors, GIP and GLP-1, that are involved in regulating appetite and blood sugar. One effect of activating these receptors is slower gastric emptying: food sits in the stomach longer than usual. That slowing is part of why appetite falls and blood-sugar spikes flatten out after meals — but it is also the main reason stomachs complain, especially in the early weeks of treatment.
If you are also noticing skin changes alongside digestive symptoms, our page on Mounjaro rash on the stomach explains what to look out for and when to seek advice. The stomach ache people describe on Mounjaro tends to sit somewhere between a dull heaviness and sharper cramping, often accompanied by nausea, bloating or a feeling of fullness that lingers well after eating. Constipation or loose stools can make it worse. The NHS tirzepatide medicines page lists abdominal pain, nausea, vomiting, diarrhoea and constipation among the common side effects, and notes that these gastrointestinal effects are the most frequently reported across the group.
Importantly, the discomfort is not a sign the medicine is harming you. It reflects the body adjusting to a new physiological signal. For people who want to understand the broader picture of how this plays out day to day, our guide to bad stomach on Mounjaro goes into more detail on how the adjustment period typically unfolds.
For most people, stomach ache with Mounjaro is most noticeable during the first one to two weeks after starting a new dose. This pattern tends to repeat with each upward step in dose, then calm again before the next increase. The licensed schedule begins at 2.5 mg, which exists partly because starting lower gives the gut time to adapt; prescribers titrate upward slowly for the same reason.
Several things reliably worsen gastrointestinal symptoms. Eating large meals is the most common culprit, the stomach is already emptying more slowly, so volume adds to the pressure. Fatty, rich or heavily spiced food has a similar effect. Eating too quickly, lying down soon after a meal, and being dehydrated can all amplify discomfort. Alcohol tends to irritate things further.
Conversely, smaller portions eaten more slowly, plain foods during the worst days, prioritising protein and fibre over fat, and keeping fluid intake steady through the day consistently help. Some people find that timing their injection matters too: if you normally inject on a Monday and you know the following two days are uncomfortable, planning lighter meals on those days (rather than discovering mid-week that your Tuesday lunch didn't agree with you) makes the pattern easier to manage. This kind of self-knowledge usually builds over the first two or three months. For more on managing this pattern specifically, see our page on sore stomach on Mounjaro.
The vast majority of stomach discomfort on tirzepatide is mild to moderate and self-limiting. There is, though, a specific pattern that needs immediate medical assessment: severe, persistent abdominal pain that may radiate to the back, with or without vomiting, particularly if it does not ease off in the way ordinary nausea does. This can be a sign of acute pancreatitis, which the MHRA highlighted as a known but infrequent serious risk with GLP-1 medicines in a Drug Safety Update published in January 2026. If you experience that kind of pain, do not wait, contact 111 or go to A&E.
Other symptoms worth raising promptly with a prescriber include: pain in the upper right abdomen (which can indicate gallbladder problems), severe vomiting that stops you keeping fluids down, or any abdominal pain that feels qualitatively different from the mild discomfort you have had before. Stomach ache that is new, intense, or accompanied by other symptoms is always worth a call rather than a wait.
If you are experiencing abdominal discomfort that feels unusual or is not settling, our page on stomach pains and Mounjaro walks through the specific distinctions in more detail. You can also contact our aftercare team, who are available seven days a week to patients treating with nume.
Not everyone does. Gastrointestinal side effects were the most commonly reported in the SURMOUNT-1 trial, which involved thousands of adults across 72 weeks of treatment, but rates varied considerably between individuals and by dose level. Some people move through the titration schedule with barely any stomach trouble; others find the lower doses more uncomfortable than the higher ones once the body has adjusted. There is no reliable way to predict who will be affected.
The good news is that for most people who do experience tirzepatide stomach ache, our detailed guide to Mounjaro stomach pain covers why the symptoms ease considerably after the first month or two as the gut adapts. A minority find discomfort persists longer, and a small number decide with their prescriber to remain on a lower dose rather than continuing to titrate up. That is a legitimate clinical choice: the prescribing framework is designed to let you find a tolerated dose rather than push through severe symptoms.
Thinking about whether Mounjaro might suit you, or weighing up the side-effect profile against potential benefit? Our prescribers can talk through your specific situation. You can also read more about how tirzepatide works overall on our tirzepatide overview, or explore treatment options more broadly on our weight-loss treatments page. When you are ready, check your eligibility with a free consultation, a real prescriber reviews every application the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.